marketcap
Integra LifeSciences Holdings Corporation IART
$ 21.8
0.0%
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-04-2024
Integra LifeSciences Holdings Corporation Balance Sheet 2011-2024 | IART
Annual Balance Sheet Integra LifeSciences Holdings Corporation
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
514 M | 125 M | 65.8 M | 951 M | 1.15 B | 1.22 B | 1.67 B | 563 M | 667 M | 558 M | 271 M | 423 M | 431 M |
Long Term Debt |
775 M | 567 M | 564 M | 1.41 B | 1.3 B | 1.33 B | 1.78 B | 665 M | 701 M | 626 M | 392 M | 520 M | 532 M |
Long Term Debt Current |
15.3 M | 14.6 M | 14.8 M | 12.8 M | 12.3 M | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | 1.56 B | 1.47 B | 1.9 B | 845 M | 884 M | 748 M | 407 M | 539 M | 550 M |
Total Current Liabilities |
307 M | 321 M | 340 M | 401 M | 331 M | 263 M | 349 M | 124 M | 139 M | 126 M | 119 M | 107 M | 102 M |
Total Liabilities |
2.19 B | 2.09 B | 2.1 B | 2.1 B | 1.89 B | 1.73 B | 2.25 B | 968 M | 1.02 B | 874 M | 526 M | 646 M | 651 M |
Deferred Revenue |
8.54 M | 7.25 M | 5.3 M | 5.28 M | 4.77 M | 3.76 M | 11.1 M | 6.81 M | 5.67 M | 5.18 M | 4.2 M | 3.5 M | 4.54 M |
Retained Earnings |
947 M | 879 M | 699 M | 532 M | 399 M | 348 M | 285 M | 220 M | 146 M | 315 M | 285 M | 302 M | 261 M |
Total Assets |
3.78 B | 3.89 B | 3.78 B | 3.62 B | 3.3 B | 3.11 B | 3.21 B | 1.81 B | 1.77 B | 1.58 B | 1.2 B | 1.16 B | 1.14 B |
Cash and Cash Equivalents |
276 M | 457 M | 513 M | 470 M | 199 M | 139 M | 175 M | 102 M | 48.1 M | 71.7 M | 121 M | 96.9 M | 101 M |
Book Value |
1.59 B | 1.8 B | 1.68 B | 1.51 B | 1.42 B | 1.38 B | 962 M | 840 M | 751 M | 704 M | 670 M | 518 M | 493 M |
Total Shareholders Equity |
1.59 B | 1.8 B | 1.68 B | 1.51 B | 1.42 B | 1.38 B | 962 M | 840 M | 751 M | 704 M | 666 M | 518 M | 493 M |
All numbers in USD currency
Quarterly Balance Sheet Integra LifeSciences Holdings Corporation
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
765 M | 770 M | 775 M | 775 M | 775 M | 775 M | 567 M | 810 M | - | 832 M | 564 M | 855 M | 866 M | 878 M | 878 M | 878 M | 878 M | 878 M | 878 M | 889 M | 900 M | 900 M | 900 M | 900 M | 900 M | 1.18 B | - | - | - | - | - | 225 M | 223 M | 221 M | 218 M | 218 M | 218 M | 218 M | 213 M | 213 M | 213 M | 213 M | 205 M | 205 M | 205 M | 205 M | 198 M | 198 M | 198 M | 198 M | 353 M | 353 M | 353 M | 353 M |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
2.54 B | 2.54 B | 2.48 B | 2.16 B | 2.09 B | 2.07 B | 2.09 B | 2.08 B | - | 2.06 B | 2.1 B | 2.14 B | 2.14 B | 2.21 B | 2.1 B | 2.1 B | 2.1 B | 2.1 B | 1.89 B | 1.89 B | 1.89 B | 1.89 B | 1.73 B | 1.73 B | 1.73 B | 1.73 B | 2.25 B | 2.25 B | 2.25 B | 2.25 B | 968 M | 968 M | 968 M | 968 M | 1.02 B | 1.02 B | 1.02 B | 1.02 B | 883 M | 883 M | 874 M | 874 M | 526 M | 526 M | 526 M | 526 M | 646 M | 646 M | 646 M | 646 M | 651 M | 656 M | 656 M | 656 M |
Deferred Revenue |
9.99 M | 9.9 M | 7.84 M | 8.14 M | 8.28 M | 7.74 M | 7.25 M | 6.36 M | - | 5.34 M | 5.3 M | 5.39 M | 5.89 M | 5.4 M | 5.28 M | 5.28 M | 5.28 M | 5.28 M | 4.77 M | 4.77 M | 4.77 M | 4.77 M | 3.76 M | 3.76 M | 3.76 M | 3.76 M | 11.1 M | 7.67 M | 8.42 M | 8.09 M | 6.81 M | 6.81 M | 6.81 M | 6.81 M | 5.67 M | 5.67 M | 5.67 M | 5.67 M | 5.18 M | 5.18 M | 5.18 M | 5.18 M | 4.2 M | 4.2 M | 4.2 M | 4.2 M | 3.5 M | 3.5 M | 3.5 M | 3.5 M | 4.54 M | 4.54 M | 4.54 M | 4.54 M |
Retained Earnings |
920 M | 931 M | 944 M | 927 M | 908 M | 903 M | 879 M | 826 M | - | 731 M | 699 M | 653 M | 610 M | 575 M | 532 M | 532 M | 532 M | 532 M | 399 M | 399 M | 399 M | 399 M | 348 M | 348 M | 348 M | 348 M | 285 M | 285 M | 285 M | 285 M | 220 M | 220 M | 220 M | 220 M | 146 M | 146 M | 146 M | 146 M | 315 M | 315 M | 315 M | 315 M | 281 M | 281 M | 281 M | 281 M | 302 M | 302 M | 302 M | 302 M | 261 M | 261 M | 261 M | 261 M |
Total Assets |
4.07 B | 4.07 B | 4.08 B | 3.74 B | 3.78 B | 3.74 B | 3.89 B | 3.81 B | - | 3.67 B | 3.78 B | 3.77 B | 3.71 B | 3.74 B | 3.62 B | 3.62 B | 3.62 B | 3.62 B | 3.3 B | 3.3 B | 3.3 B | 3.3 B | 3.11 B | 3.11 B | 3.11 B | 3.11 B | 3.21 B | 3.21 B | 3.21 B | 3.21 B | 1.81 B | 1.81 B | 1.81 B | 1.81 B | 1.77 B | 1.77 B | 1.77 B | 1.77 B | 1.59 B | 1.59 B | 1.58 B | 1.58 B | 1.19 B | 1.19 B | 1.19 B | 1.19 B | 1.16 B | 1.16 B | 1.16 B | 1.16 B | 1.14 B | 1.15 B | 1.15 B | 1.15 B |
Cash and Cash Equivalents |
215 M | 215 M | 592 M | 274 M | 309 M | 307 M | 457 M | 512 M | 447 M | 407 M | 513 M | 470 M | 397 M | 409 M | 470 M | 470 M | 470 M | 470 M | 199 M | 199 M | 199 M | 199 M | 139 M | 139 M | 139 M | 139 M | 175 M | 175 M | 175 M | 175 M | 102 M | 102 M | 102 M | 102 M | 48.1 M | 48.1 M | 48.1 M | 48.1 M | 71.7 M | 71.7 M | 72 M | 72 M | 121 M | 121 M | 121 M | 121 M | 96.9 M | 96.9 M | 96.9 M | 96.9 M | 101 M | 101 M | 101 M | 101 M |
Book Value |
1.52 B | 1.53 B | 1.6 B | 1.58 B | 1.68 B | 1.67 B | 1.8 B | 1.72 B | - | 1.62 B | 1.68 B | 1.63 B | 1.57 B | 1.53 B | 1.51 B | 1.51 B | 1.51 B | 1.51 B | 1.42 B | 1.42 B | 1.42 B | 1.42 B | 1.38 B | 1.38 B | 1.38 B | 1.38 B | 962 M | 962 M | 962 M | 962 M | 840 M | 840 M | 840 M | 840 M | 751 M | 751 M | 751 M | 751 M | 704 M | 704 M | 704 M | 704 M | 666 M | 666 M | 666 M | 666 M | 518 M | 518 M | 518 M | 518 M | 493 M | 493 M | 493 M | 493 M |
Total Shareholders Equity |
1.52 B | 1.53 B | 1.6 B | 1.58 B | 1.68 B | 1.67 B | 1.8 B | 1.72 B | 1.66 B | 1.62 B | 1.68 B | 1.63 B | 1.57 B | 1.53 B | 1.51 B | 1.51 B | 1.51 B | 1.51 B | 1.42 B | 1.42 B | 1.42 B | 1.42 B | 1.38 B | 1.38 B | 1.38 B | 1.38 B | 962 M | 962 M | 962 M | 962 M | 840 M | 840 M | 840 M | 840 M | 751 M | 751 M | 751 M | 751 M | 704 M | 704 M | 704 M | 704 M | 666 M | 666 M | 666 M | 666 M | 518 M | 518 M | 518 M | 518 M | 493 M | 493 M | 493 M | 493 M |
All numbers in USD currency